Gene therapy of Retinal Diseases


Gene therapy is growing potentially in the field of ophthalmology having mailnly three characteristics- convenience in terms of injections and eye surgery, tight blood-ocular barriers which save other organ from contamination, its immune-privileged status facilitating the accommodation to the antigenicity of a viral vector.


  • Adeno-associated Viral Gene Therapy
  • Laser Congenital Amaurosis
  • Usher’s Syndrome

Related Conference of Gene therapy of Retinal Diseases

February 18-19, 2022

32nd World Congress on Ophthalmology and Optometry

Rome, Italy
March 07-08, 2022

7th Global Pediatric Ophthalmology Congress

Barcelona, Spain
March 21-22, 2022

22nd Global Ophthalmologists Annual meeting

Amsterdam, Netherlands
April 11-12, 2022

2nd International Conference on Ophthalmology

Prague, Czech Republic
April 21-22, 2022

5th International Conference on Ear Nose and Throat

Amsterdam, Netherlands
April 26-27, 2022

European Conference on Ophthalmology & Eye care

Auckland, Newzealand
April 27-28, 2022

6th World Congress on Ophthalmology and Vision Science

Toronto, Canada
April 28-29, 2022

3rd International Conference on Optometry

Amsterdam, Netherlands
May 04-05, 2022

9th Global Ophthalmology Meeting

Prague, Czech Republic
August 01-02, 2022

World Congress on Ophthalmology and Optometry

Rome, Aland Islands
September 26-27, 2022

32nd International Congress on Vision Science and Eye

Rome, Italy
October 10-11, 2022

36th European Ophthalmology Congress

Vienna, Austria

Gene therapy of Retinal Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in